We are live on ! Find out more
MCIM

Meadow Creek Investment Management Portfolio holdings

AUM $5.09B
1-Year Est. Return 5.82%
This Fund
S&P 500
This Quarter Est. Return
+14.69%
1 Year Est. Return
+5.82%
3 Year Est. Return
+54.91%
5 Year Est. Return
10 Year Est. Return
AUM
$4.91B
AUM Growth
+$603M
Cap. Flow
+$14.5M
Cap. Flow %
0.29%
Top 10 Hldgs %
23.21%
Holding
1,377
New
62
Increased
512
Reduced
253
Closed
35

Top Buys

Rank Stock Value
1
ETN icon
Eaton
ETN
+$12.4M
2
MSFT icon
Microsoft
MSFT
+$9.88M
3
OGE icon
OGE Energy
OGE
+$9.67M
4
VZ icon
Verizon
VZ
+$9.67M
5
ALLY icon
Ally Financial
ALLY
+$8.2M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$25.1M
2
CI icon
Cigna
CI
+$18M
3
ALL icon
Allstate
ALL
+$13.6M
4
BA icon
Boeing
BA
+$11.6M
5
IFF icon
International Flavors & Fragrances
IFF
+$11M

Sector Composition

Rank Sector Weight
1 Technology 19.15%
2 Financials 14.44%
3 Healthcare 13.82%
4 Consumer Discretionary 13.32%
5 Industrials 8.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRQ
1326
DELISTED
Turquoise Hill Resources Ltd
TRQ
$16K ﹤0.01%
1,016
APPF icon
1327
AppFolio
APPF
$6.97B
$15K ﹤0.01%
192
+16
+9% +$1.07K
DNLI icon
1328
Denali Therapeutics
DNLI
$4.04B
$14K ﹤0.01%
594
GDDY icon
1329
GoDaddy
GDDY
$11.6B
$14K ﹤0.01%
192
TBHC
1330
DELISTED
The Brand House Collective
TBHC
$14K ﹤0.01%
1,958
TWST icon
1331
Twist Bioscience
TWST
$7.85B
$14K ﹤0.01%
588
-448
-43% -$10.1K
AQST icon
1332
Aquestive Therapeutics
AQST
$531M
$12K ﹤0.01%
+1,696
New +$11.9K
VCIT icon
1333
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.6B
$12K ﹤0.01%
136
ARNA
1334
DELISTED
Arena Pharmaceuticals Inc
ARNA
$12K ﹤0.01%
264
CLDR
1335
DELISTED
Cloudera, Inc.
CLDR
$11K ﹤0.01%
992
+48
+5% +$617
CRNX icon
1336
Crinetics Pharmaceuticals
CRNX
$8.96B
$8K ﹤0.01%
+340
New +$8.36K
TBPH icon
1337
Theravance Biopharma
TBPH
$878M
$8K ﹤0.01%
352
ASMB icon
1338
Assembly Biosciences
ASMB
$536M
$7K ﹤0.01%
31
-30
-49% -$7.59K
MDGL icon
1339
Madrigal Pharmaceuticals
MDGL
$12.4B
$7K ﹤0.01%
56
ESLT icon
1340
Elbit Systems
ESLT
$36.5B
$4K ﹤0.01%
32
XBI icon
1341
State Street SPDR S&P Biotech ETF
XBI
$10.5B
$1K ﹤0.01%
+16
New +$1.36K
PTE
1342
DELISTED
PolarityTE, Inc. Common Stock
PTE
$1K ﹤0.01%
4
APLS
1343
DELISTED
Apellis Pharmaceuticals
APLS
-1,296
Closed -$17K
ARVN icon
1344
Arvinas
ARVN
$580M
-110
Closed -$1K
CHRD icon
1345
Chord Energy
CHRD
$7.53B
-67,116
Closed -$371K
CNDT icon
1346
Conduent
CNDT
$241M
-24,444
Closed -$260K
DLB icon
1347
Dolby
DLB
$5.75B
-16,100
Closed -$996K
FTDR icon
1348
Frontdoor
FTDR
$5.89B
-1,848
Closed -$49K
HGV icon
1349
Hilton Grand Vacations
HGV
$3.49B
-4,096
Closed -$108K
ACH
1350
Accendra Health
ACH
$93.1M
-10,978
Closed -$69K

Similar funds

Meadow Creek Investment Management's Q1 2019 Portfolio in Review

As of Q1 2019, Meadow Creek Investment Management held 1,377 positions worth $4.91B, up 14% from $4.31B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Meadow Creek Investment Management's Q1 2019 filing shows 62 new, 512 increased, 253 reduced and 35 closed positions. Its largest new stake was Celanese: 49,308 shares worth $4.86M. The largest sale was Celgene Corp, an estimated $25.1M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Meadow Creek Investment Management's largest Q1 2019 buy was Celanese: 49,308 shares worth $4.86M.
  • Meadow Creek Investment Management added most to Eaton in Q1 2019, an estimated $12.4M increase.
  • Meadow Creek Investment Management's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $25.1M.
  • Meadow Creek Investment Management fully exited VICI Properties in Q1 2019, selling an estimated $2.71M.
  • Meadow Creek Investment Management's ten largest holdings make up 23% of its $4.91B portfolio in Q1 2019.
  • Meadow Creek Investment Management opened 62 new positions and closed 35 in Q1 2019.
  • Meadow Creek Investment Management's portfolio value rose 14% quarter-over-quarter to $4.91B.

Based on Meadow Creek Investment Management's 13F filing for Q1 2019, filed 13 May 2019.